After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Janux Therapeutics Inc is $2.34B. A total of 0.55 million shares were traded on the day, compared to an average of 562.57K shares.
In the most recent transaction, Avalon Ventures XI, L.P. sold 109,700 shares of JANX for 47.23 per share on Sep 26 ’24. After the transaction, the 10% Owner now owns 555,727 company shares. In a previous transaction on Sep 26 ’24, Avalon Ventures XI, L.P. sold 90,300 shares at 47.23 per share. JANX shares that 10% Owner owns now total 2,868,875.
Among the insiders who sold shares, Avalon Ventures XI, L.P. disposed of 57,590 shares on Sep 27 ’24 at a per-share price of $46.46. This resulted in the 10% Owner holding 546,540 shares of JANX after the transaction. In another insider transaction, Avalon Ventures XI, L.P. sold 49,231 shares at $46.45 per share on Sep 27 ’24. Company shares held by the 10% Owner now total 6,926.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, JANX has a high of $65.60 and a low of $5.65.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. JANX’s latest balance sheet shows that the firm has $374.96M in Cash & Short Term Investments as of fiscal 2021. There were $194.00k in debt and $12.80M in liabilities at the time. Its Book Value Per Share was $12.61, while its Total Shareholder’s Equity was $366.33M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JANX is Buy with a score of 4.78.
